Tag Archives: PORTLAND, Ore.

New Collaboration Strengthens Trust in Oil and Gas Certification Data

Diode and CleanConnect.ai Announce AI-Driven Framework for Verifiable Real World Assets

PORTLAND, Ore., March 17, 2026 (SEND2PRESS NEWSWIRE) — Diode, the leader in blockchain-defined networking, today announced a collaboration with CleanConnect.ai to strengthen the integrity and traceability of oil and gas production certificates. The initiative integrates Diode’s zero trust networking technology, Oasis’ privacy preserving blockchain, and CleanConnect.ai’s ProveZero multi-certification pathway system to deliver authenticated production proofs with source level provenance. The AI-driven verification framework safeguards regulated industrial information while ensuring the validity of on-chain Real World Assets (RWAs).

Image caption: Diode, the leader in blockchain-defined networking.

“Every certified performance target, every methane measurement, every evidence document is only as valuable as the trust chain behind it,” said Mark Smith, Chief Strategy Officer of CleanConnect.ai. “By routing production data generated by ProveZero through Diode’s zero-trust network and anchoring it on Oasis, we give producers, traders, and buyers cryptographic proof that the attributes encoded in every Environmental Attribute Certificate reflect real, verified, source-level data — not a registry spreadsheet someone emailed. Our ProveZero multi-certification platform can now generate tokenized energy as a verifiable Real World Asset on the blockchain, spanning ISO 14067, ISCC, EO100™, MiQ, OGMP, EUMR, and more — giving the market a single, auditable chain of custody across every major standard simultaneously.”

“We see private, automated, and cross-vendor AI systems as the next frontier for regulated data,” said Hans Rempel, CEO of Diode. “By leveraging our private AI control plane anchored on Oasis, CleanConnect.ai can rapidly deploy new assurance capabilities without sacrificing privacy, compliance, or control.”

“Oasis provides the private foundation that makes zero-trust networking so powerful for regulated industries,” said Marko Stokic, Head of AI at Oasis. “Seeing that infrastructure now underpinning real-world certification workflows in the energy sector is the kind of adoption we built for. We look forward to seeing CleanConnect.ai and Diode push the boundaries even further.”

To read the case study on how Diode, Oasis, and CleanConnect.ai are delivering verifiable Real World Assets, go to https://diode.io/blog/diode-cleanconectai-oasis-verfiable-rwa.

ABOUT OASIS

Oasis makes applications private and verifiable, empowering developers to build experiences where data ownership and user confidentiality are foundational and where user data is protected by default. Learn more at https://oasis.net/.

ABOUT CLEANCONNECT.AI

CleanConnect.ai provides AI-driven automation solutions that monitor and reduce methane emissions across oil and gas operations, enabling cost savings, regulatory compliance, and environmental sustainability in real time. Learn more at https://cleanconnect.ai/.

ABOUT DIODE

Diode is the innovation leader in Zero Trust Network Access (ZTNA) technology, providing blockchain‑secured networking that automates defense of teams, systems, and AI infrastructure while securely unlocking collaboration across organizational boundaries. Learn more at https://diode.io/.

For media inquiries, contact
Hans Rempel
media@diode.io

LOGO link for media: https://www.Send2Press.com/300dpi/26-0317-s2p-diode-300dpi.webp

NEWS SOURCE: Diode

This press release was issued on behalf of the news source (Diode), who is solely responsible for its accuracy, by Send2Press Newswire. Image, if any, was provided by the news source and not this website or the wire service. Information is believed accurate, as provided by the news source, but is not guaranteed.

To view the original story, visit: https://www.send2press.com/wire/new-collaboration-strengthens-trust-in-oil-and-gas-certification-data/

New Biography ‘The Power of His Bread’ Chronicles Fadi Arnout’s Extraordinary Life and Prophetic Dreams

PORTLAND, Ore., Oct. 22, 2024 (SEND2PRESS NEWSWIRE) — Deeply spiritual entrepreneur Fadi Arnout is the focus of an intriguing new biography by author E. A. Peters, titled “The Power Of His Bread: True Life Story Of Fadi Arnaout” (ISBN: 978-0228888246; released August, 2024 through Tellwell Publishing). This captivating narrative explores Arnout’s remarkable journey, detailing his struggles and successes in America, all through the lens of his prophetic dreams that have shaped his life and continue to guide his future.

Image caption: Cover, “The Power Of His Bread.”

“The Power of His Bread” is an inspiring biography that delves into the life of Fadi Arnout, whose dreams have provided foresight and guidance throughout his life. E. A. Peters recounts the extraordinary story of how Arnout, in 1996, dreamt of meeting a two-year-old girl who would later become a pivotal part of his life. Two decades later, this very individual walked into his restaurant, and Arnout, recognizing her from his dream, hired her without revealing his prior knowledge. This young woman, an English major taking a break from her studies, eventually wrote his life story, fulfilling the prophecy he had envisioned.

Arnout’s life is a testament to the power of faith and perseverance. His biography captures the essence of a man who has always believed in the prophetic power of his dreams. “The Power of His Bread” includes:

The early dreams that predicted significant events in Arnout’s life.
His journey as an immigrant in America and the challenges he faced.
The prophetic visions that have come true and those he believes are yet to unfold. The unique relationship with the young woman who ultimately penned his biography.

E. A. Peters masterfully captures the intersection of reality and prophecy, providing readers with a profound look at Arnout’s life. This biography is a compelling narrative of resilience, faith, and the incredible journey of a man whose dreams have been his guiding light.

Arnout himself reflects on his life and the significance of this book: “I have seen the book in my second dream in 1996, written, sold, and made a movie after I die… I didn’t believe that I would write a book …until I saw so many events happen exactly like I saw in that vivid dream of 1996. It became clear for me that I have to write my book after I saw my third dream with the Lord Jesus Christ. The more people couldn’t believe what I told them about my life the more I was convinced to write a book. I was blown away when E.A. Peters walked into the restaurant asking for the job, I knew that I had seen her face in my dream and she was the one to write it…”

“The Power of His Bread” is now available on Amazon and other online retailers.

SUMMARY:

Author: E.A. Peters

Email: authorpress@tellwell.ca

Website: FADI ARNAOUT – https://thepowerofhisbread.com/

Buy Link: https://a.co/d/6KstRXD

Genre: Memoir

Released: August 30, 2024

PAPERBACK ISBN-13: 9780228888246

Publisher: Tellwell ( https://www.tellwellpublishing.com/ )

NEWS SOURCE: Tellwell Publishing

This press release was issued on behalf of the news source (Tellwell Publishing), who is solely responsible for its accuracy, by Send2Press Newswire. Image, if any, was provided by the news source and not this website or the wire service. Information is believed accurate, as provided by the news source, but is not guaranteed.

To view the original story, visit: https://www.send2press.com/wire/new-biography-the-power-of-his-bread-chronicles-fadi-arnouts-extraordinary-life-and-prophetic-dreams/

Hasenin Al-khersan Named 2016 Koch Kellan Scholar

PORTLAND, Ore., April 18, 2016 (SEND2PRESS NEWSWIRE) -- Paragon BioTeck, Inc., announced today that Hasenin Al-khersan has been named its 2016 Koch Kellan Scholar. Paragon Gives, a Paragon BioTeck initiative, awards the Koch Kellan Scholarship to an outstanding graduate medical student committed to pursuing a clinical, teaching or research career in ophthalmology.

"The underlying principle of the Koch Kellan Scholarship is to cultivate educational opportunities and success for the next generation of ophthalmic leaders," stated Patrick Witham, President & CEO of Paragon BioTeck. "An enduring tribute to the professional lives of Doctors Koch and Kellan, it is a realization of Paragon's fundamental mission to continually elevate the standard of eye care. We do this by recognizing the talents and commitments of rising doctors such as Hasenin Al-khersan."

Hasenin Al-khersan is a third-year student at the University of Chicago Pritzker School of Medicine. As an adolescent, Mr. Al-khersan accompanied his grandmother to her glaucoma appointments, serving as a translator; later, he deepened his ophthalmic interests through cataract and glaucoma research and volunteering as the leader of Sight Savers, an international charity providing ophthalmic care in developing nations.

Upon receipt of the award, Mr. Al-khersan remarked that "Ophthalmology has long been more than an intellectual endeavor, but also a personal passion. To be recognized in this pursuit by Paragon BioTeck is humbling. I plan to continue my work in the field with Drs. Koch and Kellan; they are true examples of the impact that I may one day hope to make."

Mr. Al-khersan will join Scholarship namesakes and other distinguished industry leaders at the American Society of Cataract and Refractive Surgery annual meeting in New Orleans from May 6-8. There, he will be formally presented with the award.

About Paragon Gives and the Koch Kellan Scholarship:

Paragon Gives, a Paragon BioTeck, Inc., initiative, supports a number of charities and organizations, including those within the biotechnology and health care arena. The initiative also works with individuals and organizations that have made a positive impact on our customers, vendors, investors and industry as a whole.

The Koch Kellan Scholarship affirms Paragon's commitment to elevating the standard of eye care and enhancing patient quality of life. It was first awarded to Captain Edward Woodward of the University of South Florida Morsani College of Medicine, whose compelling personal connection to the field made him the ideal inaugural recipient.

About Paragon BioTeck, Inc.:

Paragon BioTeck, Inc., is a privately held pharmaceutical and medical device company specializing in the development and commercialization of ophthalmic pharmaceuticals, devices and therapies. Paragon BioTeck's portfolio of products is designed to protect and preserve eyesight and deliver comfort to the eyes.

For more information about Paragon BioTeck, please visit http://www.paragonbioteck.com/.

Join the conversation on Facebook at https://www.facebook.com/ParagonBioTeck/ and on Twitter at @ParagonBioTeck.

* PHOTO for media: Send2Press.com/mediaboom/16-0418-hasenin-al-khersan-300dpi.jpg

* LOGO: Send2Press.com/mediaboom/16-0418-paragonbio-300dpi.jpg

MEDIA CONTACT:
Michael Elofer
484-620-6167
mike@pascalecommunications.com

To view the original version on Send2Press Newswire, visit: https://www.send2press.com/newswire/hasenin-al-khersan-named-2016-koch-kellan-scholar-2016-0418-02.shtml.

NEWS SOURCE Paragon BioTeck, Inc. :: This press release was issued on behalf of the news source (who is solely responsible for its accuracy) by and Copr. © 2016 Send2Press® Newswire, a service of Neotrope®.

Paragon BioTeck Receives EN ISO 13485:2012 Certification

PORTLAND, Ore., March 29, 2016 (SEND2PRESS NEWSWIRE) -- Paragon BioTeck, Inc., a privately held pharmaceutical and medical device company, announced today that it has received EN ISO 13485:2012 certification, signifying the company's successful implementation of an effective quality management system.

The EN ISO 13485:2012 certification was awarded by the International Organization for Standardization, the world's largest developer and publisher of global quality and safety standards. This certification outlines specific requirements to establish and execute a structured quality management system for medical devices across all areas, from development to supply.

"Achieving this certification is an important milestone for Paragon BioTeck," said Lauren M-C Bluett, Director of Quality Assurance. "We have implemented a robust quality management system that conforms to ISO's global standards, demonstrating our commitment to excellence in product and operations through continuous improvement and quality by design."

Receipt of this certification paves the way for continued advancement of quality systems that meet world-class standards and maintain a central focus on patient safety and care.

About Paragon BioTeck, Inc.:

Paragon BioTeck, Inc., is a privately held pharmaceutical and medical device company specializing in the development and commercialization of ophthalmic pharmaceuticals, devices and therapies. Paragon BioTeck's portfolio of products is designed to protect and preserve eyesight and deliver comfort to the eyes.

These products include the Comfortear(R) Lacrisolve(TM) 180 Absorbable Punctum Plug, Comfortear(R) Punctum Plug, EqualEyes(R) Ocular Lubricant, the preservative-free ilast(R) range of products and their FDA-approved Phenylephrine Hydrochloride Ophthalmic Solution USP, available in 2.5% and 10%.

For more information about Paragon BioTeck and its products, please visit http://www.paragonbioteck.com/.

Join the conversation on Facebook ( https://www.facebook.com/ParagonBioTeck/ ) and Twitter: @ParagonBioTeck.

* LOGO for media: Send2Press.com/mediaboom/16-0329-paragonbio-300dpi.jpg

MEDIA CONTACT:
Michael Elofer
mike@pascalecommunications.com
(484) 620-6167

To view the original version on Send2Press Newswire, visit: https://www.send2press.com/newswire/paragon-bioteck-receives-en-iso-13485-2012-certification-2016-0329-02.shtml.

Paragon BioTeck to Exhibit at American Academy of Ophthalmology Annual Meeting in Chicago

PORTLAND, Ore., Oct. 15, 2014 (SEND2PRESS NEWSWIRE) -- Paragon BioTeck, Inc., a privately held biopharmaceutical and medical device company specializing in the development of ophthalmic pharmaceuticals, devices and therapies, will be exhibiting at the American Academy of Ophthalmology (Booth #4550) in Chicago, Ill., on October 18 - 21.

Visit Paragon BioTeck at booth #4550 to view their product portfolio including the recently FDA cleared medical device Comfortear(R) Lacrisolve(TM) Absorbable Punctum Plug, indicated for medium-term occlusion therapy for up to six (6) months.

The Paragon BioTeck portfolio of products are designed to protect and preserve eyesight and to deliver comfort to the eyes. Other ocular health care products showcased will include the Comfortear(R) Punctum Plug, EqualEyes(TM) Ocular Lubricant, and the preservative-free ilast(R) range of products containing hyaluronic acid (HA) formulated specifically for Eyelid Hygiene.

About Paragon BioTeck, Inc.:

Paragon BioTeck is a privately held ophthalmic-focused biopharmaceutical and medical device company pursuing the development and commercialization of products addressing unmet medical needs in the fight to protect and preserve eyesight.

For more information on the company and its work, please visit http://www.paragonbioteck.com/ or call 888-424-1192; or email info@paragonbioteck.com.

*LOGO: Send2Press.com/mediaboom/14-1015-paragonbio-300dpi.jpg .

To view the original version on Send2Press Newswire, visit: https://www.send2press.com/newswire/paragon-bioteck-to-exhibit-at-american-academy-of-ophthalmology-annual-meeting-in-chicago-2014-10-1015-003.shtml.

NEWS SOURCE Paragon BioTeck, Inc. :: This press release was issued on behalf of the news source (who is solely responsible for its accuracy) by and Copr. © 2014 Send2Press® Newswire, a service of Neotrope®.

ScoopCloud

The affordable PR newswire service